Patents by Inventor Stacey Morrow

Stacey Morrow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assays and methods for determining microbial resistance
    Patent number: 12385102
    Abstract: Assays and methods for detecting resistance to beta-lactam antibiotics including detection of multiple ?-lactamase family specific gene targets by polymerase chain reaction or microarray. One or more kits including primers and/or probes for identification of ?-lactamase genes selected from the group consisting of one or more of the following: MOX-like, FOX-like, ACC-like, ACT/MIR-like, CMY-2-like, DHA-like, CTX-M-14-like, CTX-M-15-like, VIM-like, NDM-like, IMP-like, KPC-like, and OXA-48-like, OXA-51-like, OXA-143-like, OXA-58-like, OXA-23-like, OXA-24/40-like, TEM-like, and SHV-like. A kit may also include one or more primers and/or probes for the identification a non-beta lactamase gene family which confers antibiotic resistance, such as the MCR-1 gene.
    Type: Grant
    Filed: June 9, 2023
    Date of Patent: August 12, 2025
    Assignees: STRECK, LLC, CREIGHTON UNIVERSITY
    Inventors: Maria Torres-Gonzalez, Nancy Hanson, Joel Lechner, Stephanie Cossette, Cathy Scheer, Matthew R. Kreifels, Stacey Morrow, Christopher Connelly, Laura R. Porter, Randy Fowler
  • Detection and classification of IMP carbapenemases using real-time polymerase chain reaction assay
    Patent number: 12146191
    Abstract: Systems and methods for detection and classification of IMP carbapenemases are described. In an aspect, sets of PCR primers associated with specific probes can be used to identify specific families of IMP ?-lactamases and utilize multiple primer sets to identify all IMP variants via real-time PCR assays. The sets of PCR primers can also be coupled with a fluorescent dye to detect a broad range of the IMP variants.
    Type: Grant
    Filed: May 3, 2023
    Date of Patent: November 19, 2024
    Assignee: Creighton University
    Inventors: Nancy D. Hanson, Hayden Smith, Stacey Morrow
  • ASSAYS AND METHODS FOR DETERMINING MICROBIAL RESISTANCE
    Publication number: 20240150850
    Abstract: Assays and methods for detecting resistance to beta-lactam antibiotics including detection of multiple ?-lactamase family specific gene targets by polymerase chain reaction or microarray. One or more kits including primers and/or probes for identification of ?-lactamase genes selected from the group consisting of one or more of the following: MOX-like, FOX-like, ACC-like, ACT/MIR-like, CMY-2-like, DHA-like, CTX-M-14-like, CTX-M-15-like, VIM-like, NDM-like, IMP-like, KPC-like, and OXA-48-like, OXA-51-like, OXA-143-like, OXA-58-like, OXA-23-like, OXA-24/40-like, TEM-like, and SHV-like. A kit may also include one or more primers and/or probes for the identification a non-beta lactamase gene family which confers antibiotic resistance, such as the MCR-1 gene.
    Type: Application
    Filed: June 9, 2023
    Publication date: May 9, 2024
    Inventors: Maria Torres-Gonzalez, Nancy Hanson, Joel Lechner, Stephanie Cossette, Cathy Scheer, Matthew R. Kreifels, Stacey Morrow, Christopher Connelly, Laura R. Porter, Randy Fowler
  • Assays and methods for determining microbial resistance
    Patent number: 11708614
    Abstract: Assays and methods for detecting resistance to beta-lactam antibiotics including detection of multiple ?-lactamase family specific gene targets by polymerase chain reaction or microarray. One or more kits including primers and/or probes for identification of ?-lactamase genes selected from the group consisting of one or more of the following: MOX-like, FOX-like, ACC-like, ACT/MIR-like, CMY-2-like, DHA-like, CTX-M-14-like, CTX-M-15-like, VIM-like, NDM-like, IMP-like, KPC-like, and OXA-48-like, OXA-51-like, OXA-143-like, OXA-58-like, OXA-23-like, OXA-24/40-like, TEM-like, and SHV-like. A kit may also include one or more primers and/or probes for the identification a non-beta lactamase gene family which confers antibiotic resistance, such as the MCR-1 gene.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: July 25, 2023
    Assignees: STRECK LLC, CREIGHTON UNIVERSITY
    Inventors: Maria Torres-Gonzalez, Nancy Hanson, Joel Lechner, Stephanie Cossette, Cathy Scheer, Matthew R. Kreifels, Stacey Morrow, Christopher Connelly, Laura R. Porter, Randy Fowler
  • ASSAYS AND METHODS FOR DETERMINING MICROBIAL RESISTANCE
    Publication number: 20190330685
    Abstract: Assays and methods for detecting resistance to beta-lactam antibiotics including detection of multiple ?-lactamase family specific gene targets by polymerase chain reaction or microarray. One or more kits including primers and/or probes for identification of ?-lactamase genes selected from the group consisting of one or more of the following: MOX-like, FOX-like, ACC-like, ACT/MIR-like, CMY-2-like, DHA-like, CTX-M-14-like, CTX-M-15-like, VIM-like, NDM-like, IMP-like, KPC-like, and OXA-48-like, OXA-51-like, OXA-143-like, OXA-58-like, OXA-23-like, OXA-24/40-like, TEM-like, and SHV-like. A kit may also include one or more primers and/or probes for the identification a non-beta lactamase gene family which confers antibiotic resistance, such as the MCR-1 gene.
    Type: Application
    Filed: June 15, 2017
    Publication date: October 31, 2019
    Inventors: Maria Torres, Nancy Hanson, Joel Lechner, Stephanie Cossette, Cathy Scheer, Matthew R. Kreifels, Stacey Morrow, Christopher Connelly, Laura R. Porter, Randy Fowler